Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-22-011438

President & CEO sold 12,480 shares at $10.95 ($136,656)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-02-16 Sale : show line 1 in the form −12,480 $10.95 $136,656 589,020 D
Open-market sales · 12,480 sh · avg $10.95 · $136,656
Loading xslF345X03/doc4.xml…